International Clinical Trial: First in Human Study of a Dual Targeting CD20 and CD19 CAR T Cell Treatment for Patients with B cell Blood Cancers That Have Returned or Not Responded to Treatment

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117062) titled 'First in Human Study of a Dual Targeting CD20 and CD19 CAR T Cell Treatment for Patients with B cell Blood Cancers That Have Returned or Not Responded to Treatment' on Sept. 7.

Study Type: Interventional

Study Design: Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable

Primary Sponsor: CELLOGEN THERAPEUTICS PRIVATE LIMITED

Condition: Health Condition 1: 8- Other Procedures

Intervention: Intervention1: XENCART: Phase I Clinical Trial of CD20.19 Chimeric Antigen Receptor T Cells in Patients wit...